Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Biotech Cleanroom Industry Articles
Sartorius grows operations in France and is investing 100 million euros by 2025
Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
Ohio Governor and Anchor Institutions Provide Progress Update on Cleveland Innovation District’s Pathogen Center
The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
Coveris Grows Medical Segment With Significant Investments Towards Industry 4.0
In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality.
Fully-Enclosed Modular Fill-Finish System created by Sexton Biotechnologies and BioSpherix
Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user error.
Integrity Cleanroom has launched operations in the US and is now incorporated in Texas
Integrity Cleanroom is pleased to announce that it has begun commercial transactions with a brand new ecommerce platform and a dedicated team of professionals based in Texas.
RESET® Spearheads New Airborne Particulate Monitoring Standard
Working with an international team of experts from universities on the forefront of air quality monitoring research, RESET® will be releasing a new air quality standard aimed at providing a framework for qualifying airborne particulate sensors – specifically optical particle counters – used for indoor and outdoor air quality monitoring.
Biocontainment Unit Delivered for COVID-19 Vaccine Development
Germfree delivered a 53-foot biocontainment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions.
COVID-19 Respirators – 3M Partners With Ford to Help Further Accelerate COVID-19 Response
3M and Ford are collaborating on specific ways the companies can rapidly combine complementary capabilities and resources to help meet a surge in demand for personal protective equipment due to the COVID-19 outbreak.
Medivant Health builds generic drug production facility in Chandler
Medivant Health is currently building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona. The first phase will create 10,000 square feet of manufacturing and laboratory space able to produce 40,000 vials of generic drug products every day. Medivant is a new Current Good Manufacturing Practice (CGMP) Manufacturer. Medivant is unique in that its sole purpose is to fill this generic drug shortage void. The facility is fully automated with minimal human intervention.
Comar Announces Acquisition of iMARK Molding
Comar Acquires iMARK Molding Comar, a premier plastic packaging, dispensing, and medical device provider serving the...
FDA approves the first targeted therapy to treat a rare mutation in patients with GIST
GISTs arise from specialized nerve cells found in the walls of the gastrointestinal tract. One or more mutations in the DNA of one of these cells may lead to the development of GIST.